Fotaki N - Search Results

1

Towards the development of a paediatric biopharmaceutics classification system: Results of a survey of experts.

Batchelor H, Ernest T, Flanagan T, Klein S, Turner R, Fotaki N, Storey D; EuPFI. Batchelor H, et al. Among authors: fotaki n. Int J Pharm. 2016 Sep 25;511(2):1151-7. doi: 10.1016/j.ijpharm.2016.06.115. Epub 2016 Jun 25. Int J Pharm. 2016. PMID: 27349792 Free article. Review.

2

Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.

Tomaszewska I, Karki S, Shur J, Price R, Fotaki N. Tomaszewska I, et al. Among authors: fotaki n. Int J Pharm. 2013 Sep 10;453(2):380-8. doi: 10.1016/j.ijpharm.2013.05.048. Epub 2013 May 29. Int J Pharm. 2013. PMID: 23727143

3

Mechanistic understanding of the effect of PPIs and acidic carbonated beverages on the oral absorption of itraconazole based on absorption modeling with appropriate in vitro data.

Fotaki N, Klein S. Fotaki N, et al. Mol Pharm. 2013 Nov 4;10(11):4016-23. doi: 10.1021/mp4003249. Epub 2013 Aug 29. Mol Pharm. 2013. PMID: 23947755

4

Paediatric oral biopharmaceutics: key considerations and current challenges.

Batchelor HK, Fotaki N, Klein S. Batchelor HK, et al. Among authors: fotaki n. Adv Drug Deliv Rev. 2014 Jun;73:102-26. doi: 10.1016/j.addr.2013.10.006. Epub 2013 Nov 1. Adv Drug Deliv Rev. 2014. PMID: 24189013 Free article. Review.

5

Martir J, Flanagan T, Mann J, Fotaki N. Martir J, et al. Among authors: fotaki n. J Pharm Pharmacol. 2017 Apr;69(4):384-397. doi: 10.1111/jphp.12635. Epub 2016 Oct 5. J Pharm Pharmacol. 2017. PMID: 27704550 Review.

6

Biopharmaceutical aspects and implications of excipient variability in drug product performance.

Zarmpi P, Flanagan T, Meehan E, Mann J, Fotaki N. Zarmpi P, et al. Among authors: fotaki n. Eur J Pharm Biopharm. 2017 Feb;111:1-15. doi: 10.1016/j.ejpb.2016.11.004. Epub 2016 Nov 11. Eur J Pharm Biopharm. 2017. PMID: 27845182 Free article. Review.

7

Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution.

Zarmpi P, Flanagan T, Meehan E, Mann J, Fotaki N. Zarmpi P, et al. Among authors: fotaki n. Int J Pharm. 2020 Mar 15;577:119080. doi: 10.1016/j.ijpharm.2020.119080. Epub 2020 Jan 24. Int J Pharm. 2020. PMID: 31988030

8

Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants.

Zarmpi P, Flanagan T, Meehan E, Mann J, Fotaki N. Zarmpi P, et al. Among authors: fotaki n. AAPS J. 2020 Feb 11;22(2):46. doi: 10.1208/s12248-019-0406-y. AAPS J. 2020. PMID: 32048079 Free PMC article.

9

Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC).

Zarmpi P, Flanagan T, Meehan E, Mann J, Fotaki N. Zarmpi P, et al. Among authors: fotaki n. AAPS J. 2020 Feb 18;22(2):49. doi: 10.1208/s12248-019-0411-1. AAPS J. 2020. PMID: 32072317 Free PMC article.

10

Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations.

Martir J, Flanagan T, Mann J, Fotaki N. Martir J, et al. Among authors: fotaki n. AAPS J. 2020 Mar 4;22(2):54. doi: 10.1208/s12248-020-0432-9. AAPS J. 2020. PMID: 32133550 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters